Value Line investment survey


Also found in: Acronyms.

Value Line investment survey

A proprietary service that ranks stocks for timeliness and safety.

The Value Line Investment Survey

A research survey on hundreds of stocks conducted by Value Line Inc. The Value Line Investment Survey uses financial data and other information to attempt to predict future performance for stocks representing the vast majority of American market capitalization. The Survey is available by subscription and is updated regularly.
References in periodicals archive ?
com to access our full research reports in The Value Line Investment Survey.
Financial newsletters and publications that will become required reading include: Value Line Investment Survey (800-833-0046) a weekly newsletter that evaluates some 1,700 companies, Morningstar Mutual Funds (312-697-4305), a biweekly newsletter that rates over 1,300 mutual funds and The Moneypaper (914-381-5400), a monthly newsletter that covers the dividend reinvestment plans of more than 400 companies.
For more information about the particular investment merits of Burger King and The India Fund, subscribers can peruse our full-page research reports in The Value Line Investment Survey.
For more information about the particular investment merits of Mindray and Ultratech, subscribers can peruse our full-page research reports in The Value Line Investment Survey.
The Value Line Investment Survey, Value Line's signature publication, is one of the most highly regarded and widely used independent investment research resources.
Industrial Outlook, which profiles trade forecast and import-export patterns of 350 countries; Value Line Investment Surveys, Parts 2 & 3, which offer overviews of 91 industry groups in addition to analyses of industries, companies, and financial market; and Standard & Poor's Industry Surveys, which feature forecast covering 21 industries as well as marketing and investment analysis.
Also, Value Line Investment Surveys [1983] reported that the price of Tylenol had not returned to its premium level over the prices of other pain relievers.
Morningstar and Value Line investment surveys (available in your local library) list an approximated statistic for this value, which can also be found in annual and semiannual reports from the funds themselves.